Mondaq All Regions - India: Food, Drugs, Healthcare, Life Sciences
Singh & Associates
These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
Singh & Associates
In the European Union (EU), 5 mg twice daily is the recommended dose for rheumatoid arthritis and psoriatic arthritis.
Singh & Associates
On January 15, 2019 EMA's Pharmacovigilance Risk Assessment Committee recommended an EU-wide suspension of fenspiride medicines due to the risk of QT prolongation and torsades de pointes ...
Singh & Associates
On February 28, 2019, European Medicine Agency published the first guidance on new rules for certain medical devices - the first of a series of guidance documents to help applicants to prepare for compliance with these new rules.
Singh & Associates
This is the first and only treatment for nraxSpA approved by USFDA.
Singh & Associates
On Mar 20, 2019, World Health Organization issued guidelines "WHO Consolidated Guidelines on Drug- Resistant Tuberculosis Treatment" to accelerate the treatment of tuberculosis for proper eradication of the multidrug resistant TB ...
Singh & Associates
Earlier On 27th February, 2019, National Pharmaceuticals Pricing Authority (the ‘NPPA') listed 42 anti-cancer drugs under 30% Trade Margin rationalization.
Singh & Associates
On March 06, 2019, the Central Government proposed labeling specifications for import and manufacturing permission of New Drug Formulation under form 45/46 of Schedule A of Drugs and Cosmetics Act, 1940 ...
Singh & Associates
The Rules introduced the conditions for providing post-trial access of drugs to patients who require it for the first time.
Singh & Associates
Reported draft notification on revised Rules is based on recommendations of a panel set up by the ministry on August 04, 2018.
Singh & Associates
The review further concluded that there may be a link between the use of SGLT2 inhibitor and acute pancreatic.
Cyril Amarchand Mangaldas
India is currently facing a declining fertility rate and a changing social structure, with late marriages and single parenthood becoming more common.
Nishith Desai Associates
The pharmaceuticals and life sciences industry experienced an eventful 2018 because of numerous significant legal, regulatory and policy measures announced by the government in course of the year.
Khurana and Khurana
As a child growing up in India, or even as an adult, each one of us has had a fair experience of how grandmothers in Indian households peculiarly happen to have herbal prescriptions
S.S. Rana & Co. Advocates
Recently, the Delhi High Court stayed the ban on E-Cigarettes and other Electronic Nicotine Delivery Systems.
Obhan & Associates
The branding of a new drug by pharmaceutical companies is a crucial decision for the success of that drug in the market.
Singh & Associates
In February 2019, the Government of India introduced first draft regulatory guidelines for evaluation of nanopharmaceutical products for therapeutic use in the country.
Singh & Associates
On February 26, 2019 Central Government published draft amendment to the Drug & Cosmetic Rules, 19459 to include a clause where a manufacturer / applicant intending to market a drug under a brand name ...
Singh & Associates
Central Government, in order to enhance the safety of the cosmetic products, has proposed the product composition details clause shall be mentioned in the approval issued by the licensing authority in the country.
Singh & Associates
On February 27, 2019, the National Pharmaceutical Pricing Authority or NPPA capped trade margins of 42 non-scheduled cancer drugs to curb profiteering on vital medicines notified in the Standing Order.
Latest Video
Most Popular Recent Articles
Singh & Associates
The Indian Pharmacopoeia Commission (IPC) has released the Eighth Edition of Indian Pharmacopoeia (IP-2018). It was released by the Secretary, Ministry of Health & Family Welfare, Government of India.
Kochhar & Co.
The Legal Metrology (Packaged Commodities) Rules, 2011 ("Packaging Rules") regulate pre-packaged commodities in India and inter – alia mandate certain labeling requirements prior to sale of such commodities.
Singh & Associates
AMR is a major global challenge and is getting the attention of all relevant stakeholders. Factors such as inappropriate and irrational use of antimicrobial agents among others have led to the increase in AMR.
Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
Khurana and Khurana
It cannot be debated that E-pharmacy cannot be equated with normal e-commerce platform.
Singh & Associates
On February 28, 2019, European Medicine Agency published the first guidance on new rules for certain medical devices - the first of a series of guidance documents to help applicants to prepare for compliance with these new rules.
Khaitan & Co
The e-commerce sector has grown exponentially over the last decade and has revolutionised the interplay between internet and commerce worldwide.
Obhan & Associates
The branding of a new drug by pharmaceutical companies is a crucial decision for the success of that drug in the market.
Singh & Associates
In February 2019, the Government of India introduced first draft regulatory guidelines for evaluation of nanopharmaceutical products for therapeutic use in the country.
Singh & Associates
On February 26, 2019 Central Government published draft amendment to the Drug & Cosmetic Rules, 19459 to include a clause where a manufacturer / applicant intending to market a drug under a brand name ...
Singh & Associates
The license retention fee referred to in sub-rule (1), shall be equivalent to the respective fee required for the grant of such license excluding inspection fee paid for grant of license.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with